About Hank Gracin

Hank Gracin is a nationally recognized corporate and securities partner with a track record of more than 120 IPOs and extensive experience directing billions of dollars in capital markets transactions, mergers and acquisitions, and complex business transactions.

With more than 40 years at the forefront of corporate finance, Hank has guided both domestic and foreign companies through traditional initial public offerings on the NYSE and Nasdaq, as well as direct listings and reverse mergers. His capital markets practice spans the full range of securities offerings, including follow-on public offerings, PIPEs, registered direct offerings, at-the-market offerings, private placements, preferred stock offerings, rights offerings, and venture capital and private equity funding transactions.

Hank represents nationally recognized corporations, premier high-tech companies, venture capital firms, and individual investors across a wide range of industries, with particular depth in life sciences, biotechnology, and technology. He brings a distinctive dual perspective to every engagement: he began his career at one of the top five most prestigious elite U.S. law firms before serving as in-house counsel at the then largest software company in the United States, where he negotiated more than 50 acquisitions of IT companies and software products—including several public company mergers and tender offers—and managed all legal matters involving intellectual property protection.

Clients rely on Hank as a trusted strategic advisor—and frequently as their de facto general counsel—for ongoing regulatory compliance with the SEC, NYSE, NYSE American, and Nasdaq, as well as for the preparation of proxy statements and periodic reporting (10-K, 10-Q, 8-K, and Section 16 filings). He also provides comprehensive lifecycle support, including contract drafting and negotiation, licensing, master service agreements, and board governance.

Hank earned his J.D. cum laude from New York University School of Law, where he graduated sixth in his class, was elected to the Order of the Coif, and served on the New York University Law Review. He has edited and revised portions of Private Placements and Restricted Securities (Clark Boardman Co.) and has been published on SEC matters and rulings in the New York Law Journal.

Knowledge Panel

Practice focus:

  • Mergers & Acquisitions
  • Public and Private Financings
  • Corporate Advisory Services

Industry sectors:

  • Life Sciences Firms
  • Biotech Firms
  • Healthcare Firms
  • Public Companies
  • Private Companies
  • Venture Capital Firms
  • Individual Investors
  • Underwriters

Differentiators:

  • Recognized authority in domestic and cross-border capital markets transactions
  • Trusted strategic adviser to public and private companies throughout their corporate lifecycle
  • Unique dual perspective combining elite law firm training with senior in-house experience
  • Proven track record of more than 120 IPOs and billions of dollars in transactions
  • Deep industry experience in life sciences, biotechnology, and technology sectors

A description of the standard or methodology on which the accolades are based can be found here.

Experience

  • Counsel to a private issuer engaged in the life sciences industry in a $20 million Series A Preferred Stock round and a $125 million Series B Preferred Stock round.
  • Counsel to a Nasdaq-listed developer of life sciences product candidates, with more than $100 million raised off its ATM.
  • Counsel to more than $100 million in structured debt financings.
  • Counsel to a NYSE American-listed company in the life sciences industry, with $70 million raised off its ATM offering.
  • Counsel to NYSE-American company acquisition of a company engaged in research and development in the life sciences field with upfront payments and CVRs valued at approximately $70 million.
  • Counsel to a Nasdaq-listed developer of life sciences product candidates, involving:
    • $21 million registered direct offering
    • $10 million PIPE
    • $60 million ATM
  • Counsel to a reinsurance company for a $51 million private equity investment in preferred stock.
  • Counsel to Nasdaq company acquisition of a company with commercial stage drug products in the life sciences industry.
  • Advise on a $37 million rights offering for a REIT.
  • Counsel to a private company in the gene therapy field, in connection with a $21 million Series A financing round.
  • Counsel to a $20 million private sale of a company involved in the trucking business.
  • Counsel to a private manufacturer of energy drinks in a $16 million Convertible Note Purchase financing.
  • Counsel on IPOs of life sciences companies and companies engaged in boat manufacturing.
  • Counsel on follow-on public offerings, ATMs, equity lines, and registered direct offerings for companies engaged in life sciences, gaming, technology, direct selling, coffee manufacturing, residential and commercial construction, clothing design, and real estate, in connection with their respective securities offerings.
  • Counsel to underwriters, placement agents, dealer managers, and agents, in connection with numerous IPOs, follow-on offerings, including common stock and preferred stock offerings, ATMs, and registered direct offerings.
  • Advise on licensing and sublicensing transactions.
  • Counsel on uplistings of OTC companies.
  • Advise various micro-cap and mid-cap Nasdaq- and NYSE-listed companies in connection with securities law and general corporate and corporate governance matters, including the preparation of registration statements, annual reports, quarterly reports, current reports on Form 8-K, proxy statements, annual meetings, and Section 16 filings. Also report compliance under the Exchange Act and Nasdaq and NYSE listing standards.
  • Counsel on private placements for companies across a variety of industries, including healthcare and life sciences.
  • Counsel on venture capital and private equity funding transactions, including for healthcare and life sciences companies.

A description of the standard or methodology on which the accolades are based can be found here.

Recognitions

  • 2012–2022; 2008–2009, Securities & Corporate Finance Law, New York, listed in Super Lawyers

A description of the standard or methodology on which the accolades are based can be found here.

Memberships

  • Florida Bar Association

Professional Activities

Hank serves as a member of the Business Section of the Florida Bar Association.

A description of the standard or methodology on which the accolades are based can be found here.

Bar Admissions

  • Colorado
  • Florida
  • New York

Education

  • State University of New York at Binghamton, BA, summa cum laude
  • New York University School of Law, JD, cum laude, Order of the Coif

A description of the standard or methodology on which the accolades are based can be found here.